TY  - JOUR
AU  - Yuan, Liangxi
AU  - Chen, Cheng
AU  - Li, Ziyuan
AU  - Zhu, Guanglang
AU  - Bao, Junmin
AU  - Zhao, Zhiqing
AU  - Lu, Qingsheng
AU  - Jing, Zaiping
PY  - 2018
TI  - Antiplatelet and anticoagulant for prevention of reocclusion in patients with atrial fibrillation undergoing endovascular treatment for low extremity ischemia
JF  - Journal of Thoracic Disease; Vol 10, No 3 (March 31, 2018): Journal of Thoracic Disease
Y2  - 2018
KW  - 
N2  - Background: The purpose of this study is to report the efficacy of the mono antiplatelet plus anticoagulation therapy for prevention of reocclusion in patients with atrial fibrillation (AF) undergoing endovascular treatment for lower extremity ischemia.  Methods: From March 2014 to July 2016, 32 (21 males; range, 68–84 years) patients were submitted to endovascular therapy for low extremity ischemia with AF and all were treated with endovascular treatments to correct underlying lesions. Then 20 patients receive aspirin plus rivaroxaban post-operation and 12 patients receive aspirin plus warfarin to prevent reocclusion.  Results: Complete reconstruction of occluded femopopliteal arteries with unimpeded blood flow to legs were successfully obtained in all 32 patients; 12 (37.5%) patients had acute ischemia, 17 (53.1%) patients had chronic ischemia, 3 (9.4%) patients had acute on chronic ischemia. Endovascular treatments including percutaneous transluminal angioplasty (PTA) and stenting were performed to correct residual lesions after the thrombolytic/thrombectomy procedure or to correct native lesions for chronic patients. All 32 patients showed significant improvements in symptoms and 4 patients improved completely. The mean ankle-brachial index (ABI) had risen from 0.43±0.21 preoperatively to 0.81±0.16 postoperatively (P
UR  - https://jtd.amegroups.org/article/view/19969